Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

218.50p
   
  • Change Today:
      3.50p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 249,723
  • Market Cap: £218.50m
  • RiskGrade: 125

Oxford Biomedica ups revenue forecast as AstraZeneca lifts vaccine output

By Frank Prenesti

Date: Tuesday 18 May 2021

LONDON (ShareCast) - (Sharecast News) - Gene and cell therapy group Oxford Biomedica on Tuesday doubled annual earnings guidance after pharmaceutical giant AstraZeneca ordered more Covid-19 vaccines.
Oxford Biomedica, which has an 18-month supply deal with AstraZeneca to make its AZD1222 vaccine, lifted forecasts for expected cumulative revenues to more than £100m by end-2021 from more than £50m.

As a result, Oxford Biomedica said it expected 'significant growth' in annual operating earnings for the year to end-December.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 218.50p
Change Today 3.50p
% Change 1.63 %
52 Week High 470.00
52 Week Low 166.80
Volume 249,723
Shares Issued 100.00m
Market Cap £218.50m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
36.72% above the market average36.72% above the market average36.72% above the market average36.72% above the market average36.72% above the market average
81.13% above the sector average81.13% above the sector average81.13% above the sector average81.13% above the sector average81.13% above the sector average
Price Trend
70.3% below the market average70.3% below the market average70.3% below the market average70.3% below the market average70.3% below the market average
1.75% below the sector average1.75% below the sector average1.75% below the sector average1.75% below the sector average1.75% below the sector average
Income Not Available
Growth
5.46% above the market average5.46% above the market average5.46% above the market average5.46% above the market average5.46% above the market average
51.35% above the sector average51.35% above the sector average51.35% above the sector average51.35% above the sector average51.35% above the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 6
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 24-Apr-2024

Time Volume / Share Price
17:59 26,338 @ 219.50p
17:07 2,500 @ 218.50p
16:35 13,698 @ 218.50p
16:35 240 @ 218.50p
16:35 919 @ 218.50p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page